Xylem Inc. XYL
Set alert
95.77 USD -1.49 -1.54%
As of Nov 3, 1:04 PM ET
95.01 Day range 97.26
88.23 52-week range 151.31
- YTD
- -29.68%
- 1 year
- -35.77%
- Open
- 97.21
- Prev close
- 97.26
- Mkt cap
- 21.96B
- Vol
- 675.97K
- Avg vol
- 2.54M
- EPS
- 4.51
- P/E
- 21.23
- Div yield
- 1.90%
More statistics
- Low
- 95.01
- High
- 97.26
- Forward P/E
- 16.43
- Beta
- 0.99
- Short ratio
- 4.28
- Inst. own
- 99.78%
- Dividend
- 1.72
- Ex-div date
- Aug 26, 2026
- Earnings
- Feb 9, 2027
- 50-d avg
- 105.03
- 200-d avg
- 117.30
- 1y target
- 127.69
MAX chart
Events in this range
- Mar 1, 2012Dividend: 0.1012
- Nov 2, 2015Dividend: 0.1408
- Nov 7, 2016Dividend: 0.1549
- Nov 1, 2017Dividend: 0.18
- Nov 2, 2017Dividend: 0.18
- Nov 1, 2018Dividend: 0.21
- Nov 4, 2020Dividend: 0.26
- Nov 5, 2020Dividend: 0.26
- Sep 1, 2022Dividend: 0.3
Signals (68)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Mar 1, 2026 | 8 months ago |
| SMA: Bearish | Feb 1, 2026 | 9 months ago |
| MACD: Sell Signal | Feb 1, 2026 | 9 months ago |
| MACD: Buy Signal | Jul 1, 2025 | 1 year ago |
| SMA: Bullish | May 1, 2025 | 1 year ago |
| SMA: Bearish | Mar 1, 2025 | 1 year ago |
| SMA: Bullish | Feb 1, 2025 | 1 year ago |
| MACD: Sell Signal | Dec 1, 2024 | 1 year ago |
| SMA: Bearish | Oct 1, 2024 | 2 years ago |
| MACD: Buy Signal | Dec 1, 2023 | 2 years ago |
| SMA: Bullish | Nov 1, 2023 | 3 years ago |
| SMA: Bullish | Nov 1, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 1, 2023 | 3 years ago |
| SMA: Bearish | Aug 1, 2023 | 3 years ago |
| SMA: Bearish | Aug 1, 2023 | 3 years ago |
| SMA: Bullish | Jun 1, 2023 | 3 years ago |
| SMA: Bullish | Jun 1, 2023 | 3 years ago |
| MACD: Buy Signal | Jun 1, 2023 | 3 years ago |
| SMA: Bearish | May 1, 2023 | 3 years ago |
| MACD: Sell Signal | May 1, 2023 | 3 years ago |
Newest 20 of 68.
Analyst view
Consensus: buy
Buy
Price target (mean) 127.69 +33.3% upside
Now 95.77
- Target (low)
- 90.00
- Target (mean)
- 127.69
- Target (high)
- 180.00
Ratings (0m) 21 13 buy · 7 hold · 1 sell
- Strong buy3
- Buy10
- Hold7
- Sell0
- Strong sell1
Recommendation trend
- This month 21
- 1 month ago 21
- 2 months ago 21
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.42 | 1.34 – 1.46 | 1.42 | +0.1% | 2.29B | -4.6% | 15 |
| Next quarter | 1.15 | 1.05 – 1.22 | 1.12 | +3.1% | 2.13B | +0.3% | 14 |
| Current year | 5.43 | 5.35 – 5.45 | 5.08 | +6.9% | 8.95B | -0.9% | 16 |
| Next year | 5.92 | 5.44 – 6.46 | 5.43 | +9.1% | 9.31B | +4.0% | 20 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 29, 2026 | Barclays | Downgrade | Overweight | Equal-Weight |
| Oct 28, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 28, 2026 | BNP Paribas | Maintained | Outperform | Outperform |
| Oct 28, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Oct 28, 2026 | Stifel | Maintained | Buy | Buy |
| Oct 28, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 28, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 28, 2026 | JP Morgan | Downgrade | Neutral | Underweight |
| Oct 19, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Oct 15, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Oct 14, 2026 | Oppenheimer | Reiterated | Outperform | Outperform |
| Oct 14, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 13, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 12, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 5, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 24, 2026 | Jefferies | Maintained | Buy | Buy |
| Aug 13, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 30, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 29, 2026 | Stifel | Maintained | Buy | Buy |
| Jul 29, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Jul 29, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 29, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 29, 2026 | Baird | Maintained | Outperform | Outperform |
| Jul 20, 2026 | Stifel | Maintained | Buy | Buy |
| Jul 16, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jun 25, 2026 | Jefferies | Upgrade | Hold | Buy |
| Apr 29, 2026 | UBS | Maintained | Neutral | Neutral |
| Apr 29, 2026 | Citigroup | Maintained | Buy | Buy |
| Apr 29, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
